U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
SP-8893
Preferred Name English
Ispectamab Tazide
INN  
Official Name English
ispectamab tazide [INN]
Common Name English
Immunoglobulin G1 [186,410-bis[4-(azidomethyl)-L-phenylalanine]], anti-(human tumor necrosis factor receptor superfamily protein TNFRSF17) (human-Mus musculus monoclonal SP8893 ?1-chain), disulfide with human-Mus musculus monoclonal SP8893 ?-chain, dimer
Common Name English
Code System Code Type Description
FDA UNII
6T0D8LA4M5
Created by admin on Wed Apr 02 00:44:57 GMT 2025 , Edited by admin on Wed Apr 02 00:44:57 GMT 2025
PRIMARY
SMS_ID
300000046866
Created by admin on Wed Apr 02 00:44:57 GMT 2025 , Edited by admin on Wed Apr 02 00:44:57 GMT 2025
PRIMARY
INN
12139
Created by admin on Wed Apr 02 00:44:57 GMT 2025 , Edited by admin on Wed Apr 02 00:44:57 GMT 2025
PRIMARY
CAS
2585651-78-9
Created by admin on Wed Apr 02 00:44:57 GMT 2025 , Edited by admin on Wed Apr 02 00:44:57 GMT 2025
PRIMARY
NCI_THESAURUS
C190324
Created by admin on Wed Apr 02 00:44:57 GMT 2025 , Edited by admin on Wed Apr 02 00:44:57 GMT 2025
PRIMARY
SUBSTANCE RECORD
Ispectamab Tazide
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966